Biotechnology & Life Sciences

Stock Code

PYC

Stock Exchange

ax

Phylogica (PYC) is a biopharmaceutical company engaged in the discovery and development of novel biopharmaceuticals directed at proteins and their interactions. Company was listed on Australian stockmarket (ASX) on 30 March, 2005.

Stock Code

PAA

Stock Exchange

ax

PharmAust Limited (PAA) is a unique vertically integrated pharmaceutical business involved in a range of activities from contract drug discovery and development to manufacturing, sales and marketing of healthcare & amp; pharmaceutical products. PharmAust Limited wholly owns three subsidiary companies: PharmAust Manufacturing Pty Ltd, Epichem Pty Ltd in Western Australia and Mimotopes Pty Ltd in Victoria. PAA was listed on the Australian stockmarket (ASX) on 5 October, 2001.

Stock Code

PAB

Stock Exchange

ax

Patrys (PAB) is a company that focuses on the development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer. The company has the world-wide, exclusive rights to technologies developed over 25 collective years of research and development that allow the capture, development and production of natural human antibodies for potential therapeutic applications.

Stock Code

OBJ

Stock Exchange

ax

OBJ is a drug delivery company involved in active transdermal (through-skin) drug delivery. OBJ, through its fully owned subsidiary International Scientific Limited, is developing electronic “drug patch” technologies that allow drugs, therapeutic agents and cosmetic compounds to be delivered more effectively and more efficiently through the skin.

Stock Code

NSP

Stock Exchange

ax

NuSep is a Life Science Separations Company. NuSep’s core competency is in precast gels and laboratory separation processes. Company's goal is to become a leading supplier in the life science separations market. NuSep was created from the divesture of Life Therapeutics Australian assets in October 2006. So in many respects NuSep is a new company in the Life Science market, but one with a long heritage in biological separations technology. NuSep listed on the Australian stockmarket (ASX) on 14 May, 2007.

Precast Gels

Stock Code

NDL

Stock Exchange

ax

NeuroDiscovery (NDL) is a global research and development company operating in Life Science. The company focuses on the commercialization and development of opportunities in the field of neurology. NDL was incorporated on 14 April 2005. NDL was listed on the Australian stockmarket (ASX) in August 2005 and raised $1.5 million via its IPO. The company aims to identify and evaluate investment opportunities in the Life Science sector and either invest in or acquire commercially attractive projects which the Directors believe generate shareholder value.

Stock Code

NEU

Stock Exchange

ax

Neuren Pharmaceuticals (NEU) is a biopharmaceutical company focused on the development of human therapies for neuroprotection, metabolic deficiencies and growth-related disorders. The company was formed by the merger of NeuronZ Ltd and EndocrinZ Ltd effective 1 January 2004. It has established operations in Aukland, New Zealand where majority of its employees and consultants are based. It also has an office in Australia, and Maryland in the the US. Company listed on the Australian stockmarket (ASX) on 3 February, 2005.

Stock Code

NLS

Stock Exchange

ax

Narhex Life Sciences (NLS) has developed a new class of protease inhibitors, which are a group of drugs used to treat HIV infection. The lead candidate is DG17, which when ingested is converted to DG35, the molecule with anti-HIV activity. These compounds are covered by issued or filed global patents. Three Phase IA (safety and pharmacokinetic studies in normal volunteers) and one Phase IB (safety and efficacy in short-term monotherapy of HIV infection) clinical trials have been completed, and have shown safety and some evidence of efficacy. Future clinical trials are planned for 2007.

Stock Code

MSB

Stock Exchange

ax

Mesoblast Limited (MSB) is a biotechnology company committed to the treatments for orthopaedic conditions, including the commercialisation of adult stem cell technology aimed at the regeneration and repair of bone and cartilage.

Stock Code

MVP

Stock Exchange

ax

Medical Developments International (MVP) designs, manufactures and distributes a wide range of equipment, products and devices in the anaesthetics, oxygen delivery, veterinary and asthma management fields. The company also manufactures a pre-hospital and emergency pain relief product, which is used in Australian ambulance services. MDI has three business units: pharmaceutical, medical equipment and veterinary equipment.